Thursday, October 13, 2022 Yu Zhang - National Cancer Institute Nat Med. 2022 A T cell resilience model associated with response to immunotherapy in multiple tumor types Nicholas LiaoOctober 9, 2022 Facebook0 Twitter LinkedIn0 Reddit Tumblr Pinterest0 0 Likes